Study shows capecitabine with concurrent radiation effective for gastric cancer

Links shared publicly online about this topic.

858
total visits

Study shows capecitabine with concurrent radiation effective for gastric cancer

Gastric cancer is a major cause of cancer deaths in the world. The outcome of large gastric tumors and those with lymph node involvement remains poor after surgical resection. The optimal adjuvant therapy after surgical resection remains to be determined. The most common strategies in the adjuvant treatment of gastric cancers include fluoropyrimidine-based chemotherapy with or without radiation. The introduction of capecitabine has largely replaced continuous-infusion 5-fluorouracil (5-FU) owing

View full resource at news-medical.net

Tags: Cancer, Cancer Medication, Colorectal Cancer Medication, Stomach Cancer, Xeloda, Mortality, Radiation